Accretion Pharmaceuticals, a Gujarat-based pharma manufacturer, concluded its SME IPO with a strong subscription of 7.31 times. The IPO, priced at Rs 96-101 per share, aims to utilize proceeds for capital expenditures and facility upgrades. Despite robust financial growth and international presence, the grey market premium remained flat, indicating market caution ahead of its NSE SME platform listing.
Varun Beverages Q3 net profit rises 13% YoY, but margins fall
Varun Beverages recorded a substantial net profit increase of 13.5% for the quarter ending September 2026. Although there was strong revenue growth attributed to both